MDxHealth SA (MDXH)
NASDAQ
Delayed Data
Oct 22, 2026, 01:30 PM
Day's Range
0.175552 wk Range
0.1710Overview - MDXH - MDxHealth SA
Key Statistics
Valuation
Enterprise Value
117.64M
P/E (Trailing)
-0.31
P/E (Forward)
-0.82
PEG Ratio
-0.82
Price / Sales (TTM)
0.26
Price / Book
-0.35
EV / EBITDA
-7.88
Profitability
Gross Margin
65.74%
Profit Margin
-32.74%
Operating Margin
-18.74%
Return on Assets
-9.83%
Return on Equity
277.15%
Ownership
Shares Outstanding
51.36M
Float
42.51M
Short % of Shares Outstanding
1.62%
Held by Insiders
22.14%
Held by Institutions
45.15%
Price stats
Beta
-518,287.38
50-Day Avg
0.6417
200-Day Avg
1.70
Analyst Consensus
6 analysts
Average price target
$ 2.20Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MDXH - MDxHealth SA
Peers - MDXH - MDxHealth SA
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- MDXHNASDAQMDxHealth SA19.75MMarket Cap-1900.00%52-week change-0.31P/E (Trailing)-32.74%Profit Margin
- NTRANASDAQNatera, Inc.56.71BMarket Cap+52.06%52-week change-258.91P/E (Trailing)-7.10%Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.44.20BMarket Cap-14.82%52-week change39.83P/E (Trailing)25.03%Profit Margin
- ILMNNASDAQIllumina Inc.39.64BMarket Cap+62.10%52-week change48.98P/E (Trailing)18.33%Profit Margin
- GHNASDAQGuardant Health Inc.21.18BMarket Cap+55.54%52-week change-47.56P/E (Trailing)-38.32%Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.18.25BMarket Cap+7.46%52-week change37.17P/E (Trailing)17.66%Profit Margin
- ICLRNASDAQICON plc12.97BMarket Cap-14.94%52-week change176.99P/E (Trailing)0.32%Profit Margin
Profile Summary - MDXH - MDxHealth SA
About
MDxHealth SA is a commercial-stage precision diagnostics company focused on molecular testing for urologic diseases. MDxHealth SA develops and commercializes diagnostic solutions that help physicians assess the presence, risk, and management of prostate cancer, bladder cancer, and urinary tract infections. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
